Shares of GSK plc GSK and Sanofi SA SNY are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit.
The drugmakers on Tuesday defeated thousands of lawsuits in U.S. federal court, per a court filing. The lawsuits claimed that the popular heartburn drug Zantac caused cancer. A judge found the claims were not backed by sound science.
According to data from Benzinga Pro:
- GSK closed higher by 7.85% to $37.92
- SNY closed higher by 8.06% to $48.55
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.